dc.contributor.author |
Hartkopf, Andreas |
|
dc.contributor.author |
Brucker, Sara |
|
dc.date.accessioned |
2024-08-13T06:18:25Z |
|
dc.date.available |
2024-08-13T06:18:25Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
0959-8049 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/156611 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
London : Elsevier Sci Ltd |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.ejca.2023.113480 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20240422000000_01187 |
|
utue.personen.roh |
Fasching, Peter A. |
|
utue.personen.roh |
Decker, Thomas |
|
utue.personen.roh |
Hartkopf, Andreas |
|
utue.personen.roh |
Nusch, Arnd |
|
utue.personen.roh |
Heinrich, Bernhard J. |
|
utue.personen.roh |
Kurbacher, Christian |
|
utue.personen.roh |
Fuchs, Roswitha |
|
utue.personen.roh |
Tesch, Hans |
|
utue.personen.roh |
Krabisch, Petra |
|
utue.personen.roh |
Huober, Jens |
|
utue.personen.roh |
Kuemmel, Sherko |
|
utue.personen.roh |
Brucker, Sara |
|
utue.personen.roh |
Janni, Wolfgang |
|
utue.personen.roh |
Schneeweiss, Andreas |
|
utue.personen.roh |
Schuler, Martin |
|
utue.personen.roh |
Fehm, Tanja |
|
utue.personen.roh |
Lueftner, Diana |
|
utue.personen.roh |
Quiering, Claudia |
|
utue.personen.roh |
Voges, Claudia |
|
utue.personen.roh |
Kreuzeder, Julia |
|
utue.personen.roh |
Reinisch, Mattea |
|
dcterms.isPartOf.ZSTitelID |
European Journal of Cancer |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 113480 |
de_DE |
dcterms.isPartOf.ZS-Volume |
198 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |